{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":5,"mapped":1},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P42771","source":"P42771|Cyclin-dependent kinase inhibitor 2A","targets":["1A5E|SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, 18 STRUCTURES|SOLUTION NMR||Homo sapiens|0|ANTI-ONCOGENE","1BI7|MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX|X-RAY DIFFRACTION|3.4|Homo sapiens|0|COMPLEX (KINASE/ANTI-ONCOGENE)","1DC2|SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, 20 STRUCTURES|SOLUTION NMR||Homo sapiens|0|GENE REGULATION","2A5E|SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, RESTRAINED MINIMIZED MEAN STRUCTURE|SOLUTION NMR||Homo sapiens|0|ANTI-ONCOGENE","7OZT|Nanobodies restore stability to cancer-associated mutants of tumor suppressor protein p16INK4a|X-RAY DIFFRACTION|1.74|Homo sapiens; Lama glama|0|CELL CYCLE"]}]}